Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

GW PHARMACEUTICALS LIMITED

Company number 04160917

Follow this company File for this company

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
21 Sep 2018 SH01 Statement of capital following an allotment of shares on 20 September 2018
  • GBP 340,005.196
20 Sep 2018 SH01 Statement of capital following an allotment of shares on 19 September 2018
  • GBP 339,894.16
11 Apr 2018 SH01 Statement of capital following an allotment of shares on 31 March 2018
  • GBP 338,512.9
04 Apr 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES12 ‐ Resolution of varying share rights or name
22 Mar 2018 AA Group of companies' accounts made up to 30 September 2017
28 Feb 2018 CS01 Confirmation statement made on 15 February 2018 with updates
28 Feb 2018 AP01 Appointment of Catherine Mackey as a director on 21 December 2017
28 Feb 2018 AP01 Appointment of Alicia Secor as a director on 21 December 2017
27 Feb 2018 AP01 Appointment of Lord William Arthur Waldegrave as a director on 21 December 2017
22 Dec 2017 SH01 Statement of capital following an allotment of shares on 22 December 2017
  • GBP 304,843.084
02 Oct 2017 SH01 Statement of capital following an allotment of shares on 30 September 2017
  • GBP 304,438.252
29 Sep 2017 SH01 Statement of capital following an allotment of shares on 29 September 2017
  • GBP 304,436.86
04 Jul 2017 SH01 Statement of capital following an allotment of shares on 3 July 2017
  • GBP 304,039.772
21 Apr 2017 SH01 Statement of capital following an allotment of shares on 20 April 2017
  • GBP 303,963.212
21 Mar 2017 AA Group of companies' accounts made up to 30 September 2016
20 Mar 2017 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
28 Feb 2017 SH01 Statement of capital following an allotment of shares on 28 February 2017
  • GBP 303,841.4
17 Feb 2017 CS01 Confirmation statement made on 15 February 2017 with updates
17 Feb 2017 AD03 Register(s) moved to registered inspection location Kingsgate House Newbury Road Andover SP10 4DU
17 Feb 2017 AD02 Register inspection address has been changed to Kingsgate House Newbury Road Andover SP10 4DU
13 Feb 2017 TM01 Termination of appointment of Julian Steatham Gangolli as a director on 13 February 2017
13 Feb 2017 TM01 Termination of appointment of Christopher John Tovey as a director on 13 February 2017
13 Feb 2017 TM01 Termination of appointment of Stephen Wright as a director on 13 February 2017
13 Feb 2017 TM01 Termination of appointment of Adam David George as a director on 13 February 2017
22 Dec 2016 SH01 Statement of capital following an allotment of shares on 22 December 2016
  • GBP 303,659.576